• A study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    France Germany Italy Poland Spain

  • A study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Germany Hungary Poland Spain

  • A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy

    Recruiting

    3 1
    Investigated Diseases:
    Bulgaria France Poland Romania Spain

  • A study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain

  • A study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain

  • A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Romania Spain

  • A study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Croatia Hungary Poland Portugal Slovakia Spain

  • A study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark France Italy Spain

  • A study to evaluate the safety and effectiveness of budiodarone tartrate in patients with non-permanent atrial fibrillation

    Recruiting

    4 1 1 1
    Poland

  • A study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Czechia France Germany Italy The Netherlands Poland +3

powered by